Global Silk Fibroin Biomaterials Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Silk Fibroin Biomaterials market size was valued at US$ 2.7 million in 2024 and is forecast to a readjusted size of USD 4.1 million by 2031 with a CAGR of 5.3% during review period.
Silk fibroin biomaterials are derived from silk, a natural protein fiber produced by silkworms. Fibroin, the primary structural protein of silk, is biocompatible, biodegradable, and possesses remarkable mechanical properties, including high tensile strength and elasticity. This makes it suitable for diverse biomedical applications. Silk fibroin can be processed into various forms like films, scaffolds, hydrogels, and nanoparticles. These materials are utilized in tissue engineering, drug delivery, wound healing, and biosensors due to their ability to support cell adhesion, proliferation, and differentiation, promoting tissue regeneration and controlled release of therapeutic agents.
The silk fibroin biomaterials industry is experiencing significant growth driven by the increasing demand for natural, biocompatible, and biodegradable materials in various biomedical applications. Several key trends are shaping the industry. Firstly, there's a strong focus on developing advanced silk fibroin scaffolds for tissue engineering and regenerative medicine, particularly for bone, cartilage, and skin regeneration. Researchers are exploring novel fabrication techniques like 3D printing, electrospinning, and freeze-drying to create complex and porous scaffolds that mimic the native extracellular matrix. Secondly, the use of silk fibroin in drug delivery systems is expanding rapidly. Its ability to encapsulate and release drugs, proteins, and other therapeutic agents in a controlled and sustained manner is being exploited for targeted therapies and personalized medicine. Another prominent trend is the development of silk fibroin-based wound dressings and skin substitutes. Its biocompatibility, biodegradability, and ability to promote cell proliferation and collagen synthesis make it an ideal material for promoting wound healing and reducing scarring. Furthermore, there's a growing emphasis on surface modification and functionalization of silk fibroin to enhance its bioactivity and tailor its properties for specific applications. This includes incorporating growth factors, peptides, and other bioactive molecules to improve cell interactions and tissue integration. Finally, sustainable sourcing and processing of silk fibroin are becoming increasingly important, with a focus on environmentally friendly extraction and purification methods. These trends collectively point towards a promising future for silk fibroin biomaterials in various biomedical fields, contributing to advancements in regenerative medicine, drug delivery, and wound care.
This report is a detailed and comprehensive analysis for global Silk Fibroin Biomaterials market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Silk Fibroin Biomaterials market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Silk Fibroin Biomaterials market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Silk Fibroin Biomaterials market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Silk Fibroin Biomaterials market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Silk Fibroin Biomaterials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Silk Fibroin Biomaterials market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sofregen Inc, Cocoon Biotech, CPT Sutures, Kelisema Srl, Seidecosa, SEIREN, Hanzhou Linran, Huzhou Xintiansi Bio-tech, Chongqing Haifan Biochemical, Suzhou Suhao Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Silk Fibroin Biomaterials market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Silk Fibroin Powder
Silk Amino Acids
Silk Peptide
Market segment by Application
Cosmetic & Personal Care
Biomedical
Supplements
Major players covered
Sofregen Inc
Cocoon Biotech
CPT Sutures
Kelisema Srl
Seidecosa
SEIREN
Hanzhou Linran
Huzhou Xintiansi Bio-tech
Chongqing Haifan Biochemical
Suzhou Suhao Bio
Zhejiang Xingyue Biotechnology
Cathaya
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Silk Fibroin Biomaterials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Silk Fibroin Biomaterials, with price, sales quantity, revenue, and global market share of Silk Fibroin Biomaterials from 2020 to 2025.
Chapter 3, the Silk Fibroin Biomaterials competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Silk Fibroin Biomaterials breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Silk Fibroin Biomaterials market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Silk Fibroin Biomaterials.
Chapter 14 and 15, to describe Silk Fibroin Biomaterials sales channel, distributors, customers, research findings and conclusion.
Silk fibroin biomaterials are derived from silk, a natural protein fiber produced by silkworms. Fibroin, the primary structural protein of silk, is biocompatible, biodegradable, and possesses remarkable mechanical properties, including high tensile strength and elasticity. This makes it suitable for diverse biomedical applications. Silk fibroin can be processed into various forms like films, scaffolds, hydrogels, and nanoparticles. These materials are utilized in tissue engineering, drug delivery, wound healing, and biosensors due to their ability to support cell adhesion, proliferation, and differentiation, promoting tissue regeneration and controlled release of therapeutic agents.
The silk fibroin biomaterials industry is experiencing significant growth driven by the increasing demand for natural, biocompatible, and biodegradable materials in various biomedical applications. Several key trends are shaping the industry. Firstly, there's a strong focus on developing advanced silk fibroin scaffolds for tissue engineering and regenerative medicine, particularly for bone, cartilage, and skin regeneration. Researchers are exploring novel fabrication techniques like 3D printing, electrospinning, and freeze-drying to create complex and porous scaffolds that mimic the native extracellular matrix. Secondly, the use of silk fibroin in drug delivery systems is expanding rapidly. Its ability to encapsulate and release drugs, proteins, and other therapeutic agents in a controlled and sustained manner is being exploited for targeted therapies and personalized medicine. Another prominent trend is the development of silk fibroin-based wound dressings and skin substitutes. Its biocompatibility, biodegradability, and ability to promote cell proliferation and collagen synthesis make it an ideal material for promoting wound healing and reducing scarring. Furthermore, there's a growing emphasis on surface modification and functionalization of silk fibroin to enhance its bioactivity and tailor its properties for specific applications. This includes incorporating growth factors, peptides, and other bioactive molecules to improve cell interactions and tissue integration. Finally, sustainable sourcing and processing of silk fibroin are becoming increasingly important, with a focus on environmentally friendly extraction and purification methods. These trends collectively point towards a promising future for silk fibroin biomaterials in various biomedical fields, contributing to advancements in regenerative medicine, drug delivery, and wound care.
This report is a detailed and comprehensive analysis for global Silk Fibroin Biomaterials market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Silk Fibroin Biomaterials market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Silk Fibroin Biomaterials market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Silk Fibroin Biomaterials market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Silk Fibroin Biomaterials market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Silk Fibroin Biomaterials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Silk Fibroin Biomaterials market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sofregen Inc, Cocoon Biotech, CPT Sutures, Kelisema Srl, Seidecosa, SEIREN, Hanzhou Linran, Huzhou Xintiansi Bio-tech, Chongqing Haifan Biochemical, Suzhou Suhao Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Silk Fibroin Biomaterials market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Silk Fibroin Powder
Silk Amino Acids
Silk Peptide
Market segment by Application
Cosmetic & Personal Care
Biomedical
Supplements
Major players covered
Sofregen Inc
Cocoon Biotech
CPT Sutures
Kelisema Srl
Seidecosa
SEIREN
Hanzhou Linran
Huzhou Xintiansi Bio-tech
Chongqing Haifan Biochemical
Suzhou Suhao Bio
Zhejiang Xingyue Biotechnology
Cathaya
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Silk Fibroin Biomaterials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Silk Fibroin Biomaterials, with price, sales quantity, revenue, and global market share of Silk Fibroin Biomaterials from 2020 to 2025.
Chapter 3, the Silk Fibroin Biomaterials competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Silk Fibroin Biomaterials breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Silk Fibroin Biomaterials market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Silk Fibroin Biomaterials.
Chapter 14 and 15, to describe Silk Fibroin Biomaterials sales channel, distributors, customers, research findings and conclusion.
Table of Contents
110 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Silk Fibroin Biomaterials by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
